Abstract
The term claudication is derived from the Latin word claudicatio, translated as “to limp.” In vascular disease nomenclature, claudication describes the symptom of exercise-induced muscle ischemia, most commonly due to peripheral artery disease (PAD). The patient with intermittent claudication typically describes leg pain that is caused and reliably reproduced by a certain degree of exertion. The pain is sufficiently intense to stop the activity and is promptly relieved by rest, usually within minutes. A given degree of exercise, commonly measured in pain-free distance able to walk, consistently reproduces symptoms. The Fontaine stages are commonly used to rate symptom severity (Table 51-1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997;2(3):221–226.
Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997;131(1):115–125.
Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994;74(1):64–65.
Girolami B, Bernardi E, Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 1999;159(4):337–345.
Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75(14):894–903.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837–853.
Heintzen MP, Strauer BE. Peripheral vascular effects of beta-blockers. Eur Heart J 1994;15(Suppl C):2–7.
Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A metaanalysis of randomized controlled trials. Arch Intern Med 1991;151(9):1769–1776.
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. Can J Cardiol 1996;12(2):127–137.
Nehler MR, Hiatt WR. Exercise therapy for claudication. Ann Vasc Surg 1999;13(1):109–114.
Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274(12):975–980.
Gibellini R, Fanello M, Bardile AF, Salerno M, Aloi T. Exercise training in intermittent claudication. Int Angiol 2000;19(1):8–13.
Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial. J Cardiopulm Rehabil 2002;22(3):192–198.
Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002;347(24):1941–1951.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
Schmid, JP. (2007). Rehabilitation in Peripheral Vascular Disease. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-84628-502-8_51
Download citation
DOI: https://doi.org/10.1007/978-1-84628-502-8_51
Publisher Name: Springer, London
Print ISBN: 978-1-84628-462-5
Online ISBN: 978-1-84628-502-8
eBook Packages: MedicineMedicine (R0)